Novo valuation surpasses Tesla on experimental obesity drug data
Go back to Novo valuation surpasses Tesla on experimental obesity drug data| Lilly (Eli) & Co. (NYSE: LLY) | Delayed: 1103.55 +4.98 (0.45%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1098.57 | 52 Week High | $88.16 | |||
| Open | $1112.24 | 52 Week Low | $67.88 | |||
| Day High | $1119.45 | P/E | 255.45 | |||
| Day Low | $1095.23 | EPS | $4.32 | |||
| Volume | 505,248 | |||||
| NOVO-NORDISK A/S (NYSE: NVO) | Delayed: 45.71 +2.52 (5.83%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $43.19 | 52 Week High | $59.00 | |||
| Open | $44.01 | 52 Week Low | $32.80 | |||
| Day High | $45.72 | P/E | N/A | |||
| Day Low | $43.90 | EPS | $0.00 | |||
| Volume | 5,052,141 | |||||
| ING Van Kampen Equity Growth Fund S 2 Class (NASDAQ: VKTX) | Delayed: 32.67 +2.29 (7.54%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $30.38 | 52 Week High | $5.17 | |||
| Open | $30.52 | 52 Week Low | $0.94 | |||
| Day High | $32.90 | P/E | N/A | |||
| Day Low | $30.52 | EPS | $0.00 | |||
| Volume | 1,034,015 | |||||

